{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:25:23Z","timestamp":1780514723529,"version":"3.54.1"},"reference-count":29,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Drug Safety"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:p>We present a case of probable anaphylactic shock induced by intravenous hydrocortisone in a 72-year-old male patient with septic shock. The patient, admitted for management of infected pressure injuries, was initiated on hydrocortisone (200\u2009mg\/day) for vasopressor-resistant shock. Within 30\u2009min of the first dose administration, he manifested clinical signs consistent with anaphylaxis, including refractory hypotension, tachycardia, and prolonged capillary refill time. Immediate hydrocortisone discontinuation, aggressive fluid resuscitation, norepinephrine uptitration, intravenous methylene blue administration, and amiodarone initiation for ventricular rate control resulted in hemodynamic stabilization and vital sign normalization. This event was categorized as severe (Hartwig scale level 5) and assessed as probably preventable (Modified Schoumock and Thornton scale). A Naranjo score of four supported a probable adverse drug reaction (ADR). A concurrent disulfiram-like reaction (DLR) secondary to cefoperazone-sulbactam was excluded based on clinical timeline and presentation. This case underscores that glucocorticoids, despite their anti-allergic properties, can precipitate anaphylaxis in critically ill patients, emphasizing the necessity for heightened clinical vigilance and strict adherence to administration guidelines within this vulnerable population.<\/jats:p>","DOI":"10.1177\/20420986261443460","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T09:14:01Z","timestamp":1778404441000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Probable case of anaphylaxis due to hydrocortisone in a septic shock patient"],"prefix":"10.1177","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8579-3286","authenticated-orcid":false,"given":"Yanqin","family":"Song","sequence":"first","affiliation":[{"name":"The Department of Pharmacy, The Second Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Yang","sequence":"additional","affiliation":[{"name":"The Department of Pharmacy, The Second Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingjin","family":"Zhou","sequence":"additional","affiliation":[{"name":"The Department of Intensive Care Unit, The Second Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingge","family":"Cai","sequence":"additional","affiliation":[{"name":"The Department of Pharmacy, The Second Affiliated Hospital of Yunnan University of Chinese Medicine, No. 161 Dongjiao Road, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,5,10]]},"reference":[{"issue":"6","key":"e_1_3_4_2_2","first-page":"772","article-title":"Allergic reactions to systemic glucocorticoids: a review","volume":"55","author":"Preuss L.","year":"1985","unstructured":"Preuss L. Allergic reactions to systemic glucocorticoids: a review. Ann Allergy 1985; 55(6): 772\u2013775.","journal-title":"Ann Allergy"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.18276"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62077-7"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.12.028"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.7453\/gahmj.2013.008"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000005357"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.4037\/ccn2011551"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp048052"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"issue":"9","key":"e_1_3_4_11_2","first-page":"2229","article-title":"Preventability and severity assessment in reporting adverse drug reactions","volume":"49","author":"Hartwig SC","year":"1992","unstructured":"Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992; 49(9): 2229\u20132232.","journal-title":"Am J Hosp Pharm"},{"issue":"6","key":"e_1_3_4_12_2","first-page":"538","article-title":"Focusing on the preventability of adverse drug reactions","volume":"27","author":"Schumock GT","year":"1992","unstructured":"Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992; 27(6): 538.","journal-title":"Hosp Pharm"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2005.02102001_4.x"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612033454243"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.57187\/smw.2023.40025"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2015.06.022"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1991.tb121038.x"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12441"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2012.12.004"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.3109\/02770909109089460"},{"issue":"1","key":"e_1_3_4_21_2","first-page":"47","article-title":"Disulfiram-like effect of cefonicid: first observation","volume":"81","author":"Marcon G","year":"1990","unstructured":"Marcon G, Spolaor A, Scevola M, et al. Disulfiram-like effect of cefonicid: first observation. Recenti Prog Med 1990; 81(1): 47\u201348.","journal-title":"Recenti Prog Med"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62046-7"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-013-8365-z"},{"issue":"5","key":"e_1_3_4_24_2","first-page":"480","article-title":"Current insights in sepsis: from pathogenesis to new treatment targets","volume":"17","author":"Wiersinga WJ.","year":"2011","unstructured":"Wiersinga WJ. Current insights in sepsis: from pathogenesis to new treatment targets. Curr Opin Crit Care 2011; 17(5): 480\u2013486.","journal-title":"Curr Opin Crit Care"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e31823422e8"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1159\/000057891"},{"issue":"8","key":"e_1_3_4_27_2","article-title":"Antidote or poison: a case of anaphylactic shock after intra-articular corticosteroid injection","volume":"9","author":"Sethi P","year":"2017","unstructured":"Sethi P, Treece J, Onweni C, et al. Antidote or poison: a case of anaphylactic shock after intra-articular corticosteroid injection. Cureus 2017; 9(8): e1625.","journal-title":"Cureus"},{"issue":"15","key":"e_1_3_4_28_2","article-title":"Anaphylactic reaction to intravenous glucocorticoid in a patient with chronic obstructive pulmonary disease","volume":"177","author":"Udesen PB","year":"2015","unstructured":"Udesen PB, Lindberg MJ. Anaphylactic reaction to intravenous glucocorticoid in a patient with chronic obstructive pulmonary disease. Ugeskr Laeger 2015; 177(15): V12140654.","journal-title":"Ugeskr Laeger"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajcd.2003.3222"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2011-130634"}],"container-title":["Therapeutic Advances in Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20420986261443460","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20420986261443460","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20420986261443460","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:46:14Z","timestamp":1778643974000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20420986261443460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"alternative-id":["10.1177\/20420986261443460"],"URL":"https:\/\/doi.org\/10.1177\/20420986261443460","relation":{},"ISSN":["2042-0986","2042-0994"],"issn-type":[{"value":"2042-0986","type":"print"},{"value":"2042-0994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"article-number":"20420986261443460"}}